Chitosan Phonophresis on Cervical IN Smartphone Addicted Users

ConditionCervical Pain
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-18
SponsorOctober 6 University

About this trial

A phonophoresis-based drug delivery system is a synchronous approach to improve local drug penetration in neuromuscular diseases associated with neuronal damage, excruciating pain, and local inflammation. Chitosan, a semi-synthetic material, is obtained by partial deacetylation of chitin amines, resulting in copolymers of N-acetylglucosamine and N-glucosamine. Its use has been explored in various biomaterial and medical applications. Chitosan has emerged as a cost-effective, biocompatible, and biodegradable material with many desirable biological properties, improvement of homeostasis and antiviral potential. Chitosan was found to suppress pro-inflammatory cytokines and decreased peripheral nerve edema, the polycationic nature of chitosan allows it to absorb protons, which reduces inflammation and provides an analgesic effect.

Eligibility criteria

Qualifiers

Their age will be ranged from 16-18 years

body mass index will be 26.58 kg/m2.

used a smart phone for more than 1 year for at least 2 hours per day

complaining of neck pain after using a smart phone, addiction to smart phone in accordance with the smart phone addiction scale (SAS)

Disqualifiers

any previous head and neck injuries or surgeries

any congenital abnormalities or symptomatic deformity in either the cervical or the lumbar spine

any uncorrected visual or auditory problems, dizziness, vertigo and headache

any systematic diseases, any addiction to alcohol, any additive drugs and sedatives within 48 hours previous to tests

Trial design

Treatments tested in this trial

  • Chitosan Phonophresis
  • selected physical therapy exercise

Treatment groups

30 Participants
are divided into 2 treatment groups

Sponsors and collaborators